BRUSSELS, Dec 11 (Reuters) - Johnson & Johnson (JNJ.N: Quote, Profile , Research) won conditional EU approval on Monday to buy Pfizer Inc.'s (PFE.N: Quote, Profile , Research) consumer health-care business to increase its lead in non-prescription health products.
